[Differential sensitivities of human malignant lymphoma cell lines to anti-cancer drugs].
D000970:Antineoplastic Agents / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D003561:Cytarabine / Q000494:pharmacology; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003630:Daunorubicin / Q000494:pharmacology; D004317:Doxorubicin / Q000494:pharmacology; D004351:Drug Resistance; D006801:Humans; D066298:In Vitro Techniques; D008223:Lymphoma / Q000473:pathology*
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D003561:Cytarabine; D004317:Doxorubicin; D003630:Daunorubicin